Answers are grounded in this paper and cite their sources.
Neonicotinoid insecticides (imidacloprid, clothianidin, thiacloprid, acetamiprid, thiamethoxam, nitenpyram, dinotefuran) were developed as insect-selective nicotinic acetylcholine receptor (nAChR) agonists and have long been regarded as safe for vertebrates. However, parent compounds and, more potently, desnitro metabolites such as DN-imidacloprid act on mammalian α4β2 and α7 nAChRs with nicotine-like potency, implicating cholinergic circuits central to cognition, mood, and reward. This narrative review synthesizes mechanistic, preclinical, and epidemiological evidence linking neonicotinoid exposure to neuropsychiatric risk. Mechanistically, these compounds promote glial activation, oxidative stress, blood–brain barrier (BBB) disruption, and gut microbiota alterations that converge on hippocampal and limbic dysfunction. Rodent and invertebrate studies show sex-, dose-, and exposure-window-dependent effects on anxiety-, depression-, and cognition-like behaviors, with developmental exposure mirroring prenatal nicotine effects. Human data, although limited, are convergent: poisoning case series document acute neuropsychiatric symptoms; biomonitoring studies in China, Japan, and Sri Lanka associate urinary metabolites with depression, anxiety, and a recognizable “neo-nicotinic” symptom cluster; in Mexico, studies of agricultural populations link pesticide mixtures to psychological distress, although neonicotinoid biomarkers have not yet been measured in that setting; and pediatric cohorts in China and Ecuador link prenatal and childhood exposure to impaired neurodevelopment, emotional symptoms, and hyperactivity. Collectively, this evidence is consistent with neonicotinoids being an underrecognized environmental risk factor for neuropsychiatric disorders, although the human data remain too fragmented to support causal inference and underscores the need for dedicated cohorts, expanded biomonitoring, and mechanistic research to inform regulatory assessment.
No takes yet. Share an insight, caveat, or question.
Rosas-Sánchez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: